bioMérieux

bioMérieux is a French multinational biotechnology company founded in 1963 and a world leader in in vitro diagnostics. It develops and manufactures diagnostic solutions that determine the source of disease and contamination for healthcare professionals and industry players. Its work spans pathogen detection, antimicrobial stewardship, sepsis management, food safety testing, pharmaceutical quality control, diagnostic reagents and diagnostic software. The company's product portfolio comprises diagnostic systems for rapid and accurate pathogen detection in hospital, laboratory, food safety and pharmaceutical quality-control settings; reagents used in diagnostic testing; and software supporting diagnostic workflows and decision-making. Its activities sit at the intersection of several heavily regulated sectors, including healthcare, clinical and hospital diagnostics, food safety, pharmaceutical manufacturing and laboratory testing. bioMérieux operates with a direct presence in 45 countries and serves more than 160 countries through a distribution network. Headquartered in France, it has pursued diagnostics since its founding in 1963. The company is family-owned and describes an entrepreneurial culture dating back more than a century, with a stated commitment to improving public health worldwide, enabling confident decision-making, improving patient outcomes and safeguarding consumer safety.